Key result
Higher triglyceride-glucose index linked to ~76% lower in-hospital ischemic stroke risk in COPD and AF patients.
Why the study?
Patients with COPD and AF face elevated ischemic stroke risk, and the study assessed the triglyceride-glucose index as a metabolic marker for ischemic stroke risk in this population.
Does a higher triglyceride-glucose (TyG) index predict new-onset ischemic stroke in hospitalized patients with COPD and atrial fibrillation?
Observational (n=710)
Does a higher triglyceride-glucose (TyG) index predict new-onset ischemic stroke in hospitalized patients with COPD and atrial fibrillation?
Effect estimate: aOR 0.24 (95% CI 0.10-0.57)
p-value: p=0.001
In hospitalized patients with COPD and AF, a higher TyG index was paradoxically associated with a lower risk of short-term ischemic stroke, though this may reflect reverse causality related to disease severity or malnutrition.
Should not alter stroke risk assessment in COPD-AF; leaves open reverse causality from malnutrition or severity in this observational cohort.
Purpose: Patients with chronic obstructive pulmonary disease (COPD) and atrial fibrillation (AF) face elevated ischemic stroke (IS) risk. This study assessed the triglyceride-glucose (TyG) index as a metabolic marker for IS risk in this population. Patients and Methods: This retrospective analysis included 710 hospitalized patients with COPD and AF (2014– 2024). The TyG index (ln[fasting triglycerides (mg/dL)×fasting glucose (mg/dL)/2]) measured at admission was the exposure; new-onset IS occurring during the index hospitalization (median duration: 9 days, IQR: 6– 13) was the outcome. Univariate and multivariate logistic regression (adjusting for age, sex, smoking, blood pressure, diabetes, lipids, prior stroke) identified associations. Nonlinearity was assessed using generalized additive models (GAM). Predictive performance was evaluated via ROC analysis (AUC). Results: IS occurred in 32 patients (4.5%). Unexpectedly, and in contrast to findings in the general population, higher TyG index was associated with lower IS risk in univariate analysis (OR=0.49, 95% CI:0.26– 0.94). After full adjustment, each unit increase in TyG index was associated with lower IS risk (aOR=0.24, 95% CI:0.10– 0.57, P =0.001). However, the wide confidence interval and limited events (n=32) indicate this large effect estimate should be interpreted cautiously, as it may reflect statistical instability. The finding suggests a potential metabolic paradox in this population. GAM confirmed a linear inverse relationship after adjusting for stroke history (OR=0.50, 95% CI:0.30– 0.90, P=0.032). The TyG index predicted IS with an AUC of 0.614 (95% CI:0.513– 0.715). Conclusion: Contrary to observations in the general population, in hospitalized COPD and AF patients, a higher TyG index was associated with lower short-term ischemic stroke risk. However, this inverse association could reflect either a true inverse metabolic relationship or reverse causality whereby low TyG marks disease severity (malnutrition, poor metabolic reserve, chronic inflammation). Lack of comprehensive disease severity and nutritional assessments limits causal inference. The TyG index may serve as a potential biomarker in hospitalized patients, but population-based studies are essential to address selection bias.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted an observational in Chronic obstructive pulmonary disease (COPD) and atrial fibrillation (AF) (n=710). Triglyceride-glucose (TyG) index was evaluated on New-onset ischemic stroke during the index hospitalization (aOR 0.24, 95% CI 0.10-0.57, p=0.001). Higher triglyceride-glucose index was associated with lower short-term ischemic stroke risk in hospitalized patients with COPD and atrial fibrillation (aOR 0.24; 95% CI 0.10-0.57; P=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: